![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:ATG5-AK9 (FusionGDB2 ID:HG9474TG221264) |
Fusion Gene Summary for ATG5-AK9 |
![]() |
Fusion gene information | Fusion gene name: ATG5-AK9 | Fusion gene ID: hg9474tg221264 | Hgene | Tgene | Gene symbol | ATG5 | AK9 | Gene ID | 9474 | 221264 |
Gene name | autophagy related 5 | adenylate kinase 9 | |
Synonyms | APG5|APG5-LIKE|APG5L|ASP|SCAR25|hAPG5 | AK 9|AKD1|AKD2|C6orf199|C6orf224|dJ70A9.1 | |
Cytomap | ('ATG5')('AK9') 6q21 | 6q21 | |
Type of gene | protein-coding | protein-coding | |
Description | autophagy protein 5APG5 autophagy 5-likeATG5 autophagy related 5 homologapoptosis-specific protein | adenylate kinase 9adenylate kinase domain containing 1adenylate kinase domain containing 2 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000343245, ENST00000360666, ENST00000369070, ENST00000369076, ENST00000475645, | ||
Fusion gene scores | * DoF score | 25 X 16 X 9=3600 | 3 X 3 X 2=18 |
# samples | 29 | 3 | |
** MAII score | log2(29/3600*10)=-3.6338721012021 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: ATG5 [Title/Abstract] AND AK9 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ATG5(106696025)-AK9(109980616), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | ATG5-AK9 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ATG5-AK9 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ATG5-AK9 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ATG5-AK9 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | AK9 | GO:0006174 | dADP phosphorylation | 23416111 |
Tgene | AK9 | GO:0006186 | dGDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0006756 | AMP phosphorylation | 23416111 |
Tgene | AK9 | GO:0006757 | ATP generation from ADP | 23416111 |
Tgene | AK9 | GO:0061508 | CDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061565 | dAMP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061566 | CMP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061567 | dCMP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061568 | GDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061569 | UDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061570 | dCDP phosphorylation | 23416111 |
Tgene | AK9 | GO:0061571 | TDP phosphorylation | 23416111 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-EW-A6S9-01A | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
Top |
Fusion Gene ORF analysis for ATG5-AK9 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000343245 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000343245 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000343245 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000360666 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000360666 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000360666 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369070 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369070 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369070 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369076 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369076 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-5UTR | ENST00000369076 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-intron | ENST00000343245 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-intron | ENST00000360666 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-intron | ENST00000369070 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
5CDS-intron | ENST00000369076 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
Frame-shift | ENST00000360666 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
Frame-shift | ENST00000369070 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
Frame-shift | ENST00000369076 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
In-frame | ENST00000343245 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-3CDS | ENST00000475645 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-5UTR | ENST00000475645 | ENST00000285397 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-5UTR | ENST00000475645 | ENST00000341338 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-5UTR | ENST00000475645 | ENST00000368948 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
intron-intron | ENST00000475645 | ENST00000355283 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000343245 | ATG5 | chr6 | 106696025 | - | ENST00000424296 | AK9 | chr6 | 109980616 | - | 6578 | 773 | 200 | 6064 | 1954 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000343245 | ENST00000424296 | ATG5 | chr6 | 106696025 | - | AK9 | chr6 | 109980616 | - | 0.001111748 | 0.9988883 |
Top |
Fusion Genomic Features for ATG5-AK9 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
![]() |
![]() |
Top |
Fusion Protein Features for ATG5-AK9 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr6:106696025/chr6:109980616) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 443_485 | 148 | 422.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 676_711 | 148 | 422.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 443_485 | 0 | 337.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 676_711 | 0 | 337.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 443_485 | 148 | 1912.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 676_711 | 148 | 1912.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 198_275 | 148 | 422.0 | Compositional bias | Note=Glu-rich | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 198_275 | 0 | 337.0 | Compositional bias | Note=Glu-rich | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 198_275 | 148 | 1912.0 | Compositional bias | Note=Glu-rich | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1001_1006 | 148 | 422.0 | Nucleotide binding | ATP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1050_1052 | 148 | 422.0 | Nucleotide binding | AMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1079_1082 | 148 | 422.0 | Nucleotide binding | AMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1421_1426 | 148 | 422.0 | Nucleotide binding | ATP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1470_1472 | 148 | 422.0 | Nucleotide binding | AMP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1499_1502 | 148 | 422.0 | Nucleotide binding | AMP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1001_1006 | 0 | 337.0 | Nucleotide binding | ATP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1050_1052 | 0 | 337.0 | Nucleotide binding | AMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1079_1082 | 0 | 337.0 | Nucleotide binding | AMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 116_119 | 0 | 337.0 | Nucleotide binding | AMP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1421_1426 | 0 | 337.0 | Nucleotide binding | ATP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1470_1472 | 0 | 337.0 | Nucleotide binding | AMP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1499_1502 | 0 | 337.0 | Nucleotide binding | AMP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 40_45 | 0 | 337.0 | Nucleotide binding | ATP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 87_89 | 0 | 337.0 | Nucleotide binding | AMP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1001_1006 | 148 | 1912.0 | Nucleotide binding | ATP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1050_1052 | 148 | 1912.0 | Nucleotide binding | AMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1079_1082 | 148 | 1912.0 | Nucleotide binding | AMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1421_1426 | 148 | 1912.0 | Nucleotide binding | ATP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1470_1472 | 148 | 1912.0 | Nucleotide binding | AMP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1499_1502 | 148 | 1912.0 | Nucleotide binding | AMP 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1021_1052 | 148 | 422.0 | Region | NMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1124_1144 | 148 | 422.0 | Region | LID 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1412_1601 | 148 | 422.0 | Region | Adenylate kinase 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1441_1472 | 148 | 422.0 | Region | NMPbind 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 1536_1550 | 148 | 422.0 | Region | LID 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 160_205 | 148 | 422.0 | Region | LID 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 992_1203 | 148 | 422.0 | Region | Adenylate kinase 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1021_1052 | 0 | 337.0 | Region | NMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1124_1144 | 0 | 337.0 | Region | LID 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1412_1601 | 0 | 337.0 | Region | Adenylate kinase 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1441_1472 | 0 | 337.0 | Region | NMPbind 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 1536_1550 | 0 | 337.0 | Region | LID 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 160_205 | 0 | 337.0 | Region | LID 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 31_285 | 0 | 337.0 | Region | Adenylate kinase 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 60_89 | 0 | 337.0 | Region | NMP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000355283 | 0 | 5 | 992_1203 | 0 | 337.0 | Region | Adenylate kinase 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1021_1052 | 148 | 1912.0 | Region | NMP 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1124_1144 | 148 | 1912.0 | Region | LID 2 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1412_1601 | 148 | 1912.0 | Region | Adenylate kinase 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1441_1472 | 148 | 1912.0 | Region | NMPbind 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 1536_1550 | 148 | 1912.0 | Region | LID 3 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 160_205 | 148 | 1912.0 | Region | LID 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 992_1203 | 148 | 1912.0 | Region | Adenylate kinase 2 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 116_119 | 148 | 422.0 | Nucleotide binding | AMP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 40_45 | 148 | 422.0 | Nucleotide binding | ATP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 87_89 | 148 | 422.0 | Nucleotide binding | AMP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 116_119 | 148 | 1912.0 | Nucleotide binding | AMP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 40_45 | 148 | 1912.0 | Nucleotide binding | ATP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 87_89 | 148 | 1912.0 | Nucleotide binding | AMP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 31_285 | 148 | 422.0 | Region | Adenylate kinase 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000285397 | 5 | 12 | 60_89 | 148 | 422.0 | Region | NMP 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 31_285 | 148 | 1912.0 | Region | Adenylate kinase 1 | |
Tgene | AK9 | chr6:106696025 | chr6:109980616 | ENST00000424296 | 5 | 41 | 60_89 | 148 | 1912.0 | Region | NMP 1 |
Top |
Fusion Gene Sequence for ATG5-AK9 |
![]() |
>7583_7583_1_ATG5-AK9_ATG5_chr6_106696025_ENST00000343245_AK9_chr6_109980616_ENST00000424296_length(transcript)=6578nt_BP=773nt GCCCGCCCGGCCGCGATGGCGGGTGAAGGTGGTTCCTCCGGGCAAGGTGGAGTTGGCGAGACGCCGGCCCGGAGCCCTGGGGCCGGTTGG CGGGTGTGGCCTGCGGGGTCCCTCTTGGGGTACATGTCTGTTGCTTACTAAGTTTGGCTTTGGTTGAAATAAGAATTTAGCCTGTATGTA CTGCTTTAACTCCTGGAAGAATGACAGATGACAAAGATGTGCTTCGAGATGTGTGGTTTGGACGAATTCCAACTTGTTTCACGCTATATC AGGATGAGATAACTGAAAGGGAAGCAGAACCATACTATTTGCTTTTGCCAAGAGTAAGTTATTTGACGTTGGTAACTGACAAAGTGAAAA AGCACTTTCAGAAGGTTATGAGACAAGAAGACATTAGTGAGATATGGTTTGAATATGAAGGCACACCACTGAAATGGCATTATCCAATTG GTTTGCTATTTGATCTTCTTGCATCAAGTTCAGCTCTTCCTTGGAACATCACAGTACATTTTAAGAGTTTTCCAGAAAAAGACCTTCTGC ACTGTCCATCTAAGGATGCAATTGAAGCTCATTTTATGTCATGTATGAAAGAAGCTGATGCTTTAAAACATAAAAGTCAAGTAATCAATG AAATGCAGAAAAAAGATCACAAGCAACTCTGGATGGGATTGCAAAATGACAGATTTGACCAGTTTTGGGCCATCAATCGGAAACTCATGG AATATCCTGCAGAAGAAAATGGATTTCGTTATATCCCCTTTAGAATATATCAGTGTCCTGACTATGATTTGTGCCAGAGAATTTCTGGGC AAAGACAGCACAATAATACGGGATACATATACAGTAGAGACCAGTGGGATCCTGAAGTCATTGAGAATCATAGGAAAAAGAAGAAAGAAG CCCAAAAGGACGGAAAAGGAGAAGAGGAAGAAGAGGAAGAAGAGCAAGAAGAAGAAGAGGCATTTATTGCCGAAATGCAGATGGTGGCTG AAATTCTTCATCATCTAGTTCAGAGGCCTGAAGATTATTTGGAAAATGTTGAAAACATTGTTAAGCTTTATAAGGAAACAATTCTCCAAA CTTTAGAAGAAGTAATGGCTGAACACAATCCCCAGTATCTCATTGAGCTAAATGGAAATAAACCAGCAGAGGAGCTCTTTATGATTGTTA TGGATCGACTTAAATATCTGAACCTAAAAAGAGCAGCTATTCTAACCAAACTTCAGGGTGCAGAGGAAGAAATTAATGACACAATGGAAA ATGATGAGCTATTTCGTACTCTTGCATCTTATAAACTTATTGCACCAAGATACAGATGGCAAAGAAGTAAATGGGGACGTACATGTCCTG TGAATTTAAAAGATGGTAACATTTATTCAGGATTACCAGATTATTCTGTGAGTTTTCTAGGTAAAATCTACTGTCTTTCATCAGAAGAAG CATTAAAACCATTTTTGTTGAACCCACGTCCCTATCTGCTTCCACCTATGCCAGGACCACCATGTAAAGTATTCATACTTGGACCTCAAT ATTCAGGGAAAACAACACTTTGCAATATGCTTGCAGAAAATTACAAAGGAAAGGTAGTCGACTATGCCCAACTTGTTCAGCCACGTTTTG ATAAAGCCCGTGAAACATTAGTAGAAAATACCATAGCTGAGGCCACTGCAGCAGCAATTAAAGTTGTGAAAGAAAAGCTTCTCAGGGAAC TGCAAGCTAGAAAACAAGCTGAAACAGCTTTAAGAGAATTTCAAAGGCAATATGAAAAAATGGAGTTTGGAGTATTCCCAATGGAGGCAA CACACTCATCAATTGATGAAGAAGGGTACATTCAAGGCTCCCAAAGGGACAGAGGCAGCTCTTTAGTGGACACCGAAGAAGCCAAAACAA AGTCAGAAAATGTCCTCCATGATCAAGCTGCTAAAGTTGATAAAGATGATGGAAAAGAAACTGGTGAAACATTCACATTTAAAAGGCATT CTCAAGATGCTAGTCAAGATGTAAAGTTGTATTCAGATACAGCCCCAACAGAAGACTTGATAGAAGAGGTAACTGCAGATCATCCAGAGG TTGTGACCATGATTGAAGAGACTATAAAAATGTCACAGGATATAAACTTTGAACAGCCATATGAAAAACATGCTGAAATCTTACAGGAAG TCCTTGGAGAGGTAATGGAAGAAAACAAGGATAGGTTTCCTGGTGCCCCAAAATATGGAGGCTGGATTGTGGACAACTGCCCTATTGTAA AAGAATTGTGGATGGCCTTAATCAAGAAAGGAATTATACCTGATTTGGTCATCTATTTATCAGATACAGAAAACAATGGAAAATGTTTAT TTAATAGAATATATTTACAGAAGAAATCTGAAATTGACTCTAAGATTTTAGAAAGATTATTAGAAGAACTACAAAAGAAAAAAAAAGAAG AAGAAGAAGCAAGAAAAGCCACAGAAGAGGAATTGAGACTCGAAGAAGAAAATCGAAGGCTACTGGAACTTATGAAAGTGAAGGCAAAAG AAGCTGAAGAGACTGATAATGAGGATGAAGAGGAGATTGAAGGTGATGAGTTGGAAGTTCACGAAGAGCCTGAGGCATCTCACGATACCC GAGGGTCATGGTTACCTGAGGAGTTTGAAGCATCTGAGGTCCCTGAAACTGAGCCTGAAGCAGTATCTGAGCCTATCGAGGAAACTACAG TGGAAACAGAAATCCCAAAAGGATCCAAAGAGGGCCTGGAAATTGAAAAATTATCTGAAACAGTTGTACTACCTGAGTTTCCAGAAGACT CTTATCCTGATGTTCCCGAAATGGAGCCATTTAAAGAGAAGATTGGTTCTTTCATCATCCTCTGGAAACAGCTAGAAGCAACAATTAGTG AGGCTTACATTAAAATTTTAAACTTGGAGATTGCTGACAGAACTCCACAGGAATTACTTCAAAAAGTAGTTGAGACTATGGAAAAACCAT TTCAATATACTGCATGGGAGTTAACTGGGGAAGATTATGAGGAAGAAACAGAAGACTACCAGACTGAAGCAGAGGTTGATGAGGAGCTAG AGGAAGAGGAAGAGGAAGAGGGTGAAGATAAAATGAAGGAGAGAAAGAGGCATTTGGGAGACACAAAACACTTTTGTCCGGTGGTCCTCA AAGAAAACTTCATCCTGCAACCAGGAAACACAGAAGAAGCAGCCAAGTATCGAGAAAAGATCTACTACTTTTCAAGTGCTGAGGCTAAAG AAAAGTTTTTGGAGCATCCTGAGGATTATGTGGCTCATGAAGAACCATTGAAGGCTCCTCCATTAAGAATATGCCTTGTCGGCCCCCAGG GCTCTGGCAAAACTATGTGTGGAAGACAGTTGGCAGAAAAATTAAACATTTTTCACATTCAGTTTGAAGAAGTTCTTCAAGAAAAACTAC TACTCAAAACTGAAAAGAAAGTGGGACCTGAATTTGAGGAAGATTCTGAGAACGAGCAAGCTGCCAAACAAGAACTTGAAGAGCTTGCAA TTCAGGCCAATGTCAAAGTTGAGGAAGAAAATACAAAAAAGCAGCTTCCAGAAGTACAACTTACAGAAGAAGAAGAAGTAATCAAATCAA GTCTAATGGAAAATGAGCCCTTGCCTCCTGAAATTCTTGAAGTAATTCTTTCTGAGTGGTGGCTTAAGGAACCAATACGTTCCACAGGTT TTATATTAGATGGTTTCCCACGATATCCAGAAGAGGCCCAGTTTTTGGGAGATCGTGGATTTTTCCCAGATGCAGCTGTTTTTATACAAG TTGATGATCAAGATATTTTTGATCGCCTCCTTCCTGCCCAAATTGAAAAGTGGAAACTAAAACAAAAGAAGAAATTAGAAAGGAAGAAAC TGATCAAAGACATGAAGGCAAAAATCAGGGTTGATACGATTGCTAAAAGAAGGGCTGAACTTATATTAGAGAGAGATAAAAAAAGGAGGG AGAATGTTGTTAGAGATGATGAAGAGATTAGTGAGGAAGAACTTGAAGAAGACAATGATGATATTGAAAACATCCTTGAAGATGAGTTTC CAAAAGATGAGGAAGAGATGAGTGGCGAGGAAGATGAAGAACAGGAAACTGATGCAATTGAGCGCCTGAGAGGTGAACTAGGAGAAAAAT TTGAAGCAGATACACATAATTTACAAATAATACAGGATGAACTTGAGAGGTATTTGATACCAATAATTTCCATTAATGGAGCTCGGAGAA ATCACATTGTACAATATACATTGAATATGAAACTGAAACCACTGGTGGAAAATCGTGCAAGCATTTTTGAGAAATGTCATCCAATACCAG CACCCCTTGCCCAGAAAATGCTCACCTTTACCTACAAGTATATAAGCTCATTCGGCTATTGGGACCCTGTAAAGCTAAGTGAAGGAGAGA CAATCAAGCCAGTTGAAAATGCAGAGAATCCAATTTATCCTGTAATCCATCGTCAGTATATTTATTTTTTATCTAGTAAAGAAACAAAAG AAAAATTTATGAAGAACCCAATCAAATATATCCGCCAACCCAAACCTAAGCCTACTGTGCCCATTAGGATTATAATTGTGGGGCCTCCAA AATCTGGGAAAACTACAGTTGCCAAAAAAATTACAAGTGAATATGGGTTAAAGCATTTATCAATAGGAGGAGCTTTGCGTTATGTACTAA ACAATCACCCGGAAACAGAGCTGGCACTTATGTTAAATTGGCATCTTCATAAAGGAATGACAGCACCTGATGAACTGGCTATTCAAGCCT TAGAACTTTCTCTGATGGAAAGTGTGTGCAATACTGCAGGTGTTGTCATCGATGGATATCCTGTAACTAAACATCAAATGAATCTCTTGG AAGCTAGGTCAATCATTCCCATGGTCATCTTTGAATTGAGTGTGCCTTCCAAGGAGATTTTCAAAAGATTGCTCCTAGAAAAAGAAAATG AACAAAGATTGCCTTATCCATTGCACAATAGTGCACAAATTGTAGCTGTCAATAATGTAAAGTATCGCAAAAATATTGGTGAGATTAGGC AATATTATCAAGAACAGCATCAGAACTGGTATGTGATTGATGGATTTCACAGCAAATGGTGGGTATGGAATGAAGTCATTAAGAATGTTC AAATGGTGAATAAATACATGCAGACATACCTGGAAAGAATAAAAGCAGGAAAAGCTGCCTGCATTGACAAGTTATGTATCACACCTCAAG AGCTGCTTTCTCGCCTGGGAGAATTTGAACAGTTCTGCCCTGTCAGCCTGGCAGAATCCCAGGAATTATTTGATTGCTCTGCAACTGACT CCTTGGAATTTGCAGCAGAGTTCAGGGGGCACTACTATAAAATGAGTTCTCAGGAAAAACTGAATAAATTCTTGGAGAACCCAGAATTGT ACGTGCCTCCCTTAGCACCTCATCCACTCCCATCTGCTGACATGATCCCCAAAAGACTGACACTGTCAGAGCTGAAGAGTCGATTCCCTA AGTGTGCGGAGCTCCAGGGCTACTGTCCAGTGACCTATAAGGATGGAAACCAAAGATATGAAGCTCTAGTACCTGGTAGCATTAACTATG CTTTAGAATATCATAATCGTATATATATTTGTGAGAACAAAGAAAAACTCCAGAAATTTTTGAGGTCGCCACTGAAATACTGGGAACAGA AGCTTCCACACAAGCTTCCCCCATTAAGGGAACCGATACTTCTTACTAGTCTTCCTTTGCCTGGATATCTGGAACAGGGTATTGCAACTT CTCTAATTAAAGCAATGAATGCAGCGGGATGCTTAAAGCCCAAGTTCCCCTTTTTAAGTATAAGGAGATCTGCACTGCTATATATAGCAC TTCATCTCAAAGCATTTAATCCCAAAGGTTCCGAATACACAAGAAAAAAGTATAAGAAGAAGATGGAGCAGTTTATGGAGAGTTGTGAAC TCATAACATACTTGGGTGCCAAGATGACCAGAAAATACAAGGAACCTCAGTTCAGAGCCATTGACTTTGATCATAAGTTAAAGACCTTTC TCTCTCTCAGAAATATAGACCCAATTAATGGGTAGTTTACTTAGGTGATAGCAGCCTGAATCTCAAGAGTTATCTGAAAGTGATAGAGGG AAACTGAGAGAAGTAGATTGAAAATCTGGGCCTCTTGGAAGTACTTTTGCCTCCTGAGCAAGGTACCATGGCTGCCAGACTTCAGGTGAA CTCAAAGGTCTGCCAGCCAGGAAGGAGCACTCTTATGGAAACAAGTTTTAATACAATTTTAAAATGTATTGCTCTTTGCCTGAACTTTGA TGCTTTAACAAAATAAACATTCTATTTATAATTCCATATAGAAAAGTTAAGTGACTTATTTAATAAATGTATTATTTTCCTTTTTAACAT TTTCAGTAGAAAAGTCAGTCTCTGTTAAAATTACTCATTAAATGTTAGAAAGCTTTAAGACATTTAACATTGTTATAAATGAAACCAAAA TATGGGTTATACATTTTACATACAAAACTGTTTGTGAACTTTGTGAACATAAGATACTATCATTTTCCCAATAAAATAAATGGATTTTGC >7583_7583_1_ATG5-AK9_ATG5_chr6_106696025_ENST00000343245_AK9_chr6_109980616_ENST00000424296_length(amino acids)=1954AA_BP=191 MTDDKDVLRDVWFGRIPTCFTLYQDEITEREAEPYYLLLPRVSYLTLVTDKVKKHFQKVMRQEDISEIWFEYEGTPLKWHYPIGLLFDLL ASSSALPWNITVHFKSFPEKDLLHCPSKDAIEAHFMSCMKEADALKHKSQVINEMQKKDHKQLWMGLQNDRFDQFWAINRKLMEYPAEEN GFRYIPFRIYQCPDYDLCQRISGQRQHNNTGYIYSRDQWDPEVIENHRKKKKEAQKDGKGEEEEEEEEQEEEEAFIAEMQMVAEILHHLV QRPEDYLENVENIVKLYKETILQTLEEVMAEHNPQYLIELNGNKPAEELFMIVMDRLKYLNLKRAAILTKLQGAEEEINDTMENDELFRT LASYKLIAPRYRWQRSKWGRTCPVNLKDGNIYSGLPDYSVSFLGKIYCLSSEEALKPFLLNPRPYLLPPMPGPPCKVFILGPQYSGKTTL CNMLAENYKGKVVDYAQLVQPRFDKARETLVENTIAEATAAAIKVVKEKLLRELQARKQAETALREFQRQYEKMEFGVFPMEATHSSIDE EGYIQGSQRDRGSSLVDTEEAKTKSENVLHDQAAKVDKDDGKETGETFTFKRHSQDASQDVKLYSDTAPTEDLIEEVTADHPEVVTMIEE TIKMSQDINFEQPYEKHAEILQEVLGEVMEENKDRFPGAPKYGGWIVDNCPIVKELWMALIKKGIIPDLVIYLSDTENNGKCLFNRIYLQ KKSEIDSKILERLLEELQKKKKEEEEARKATEEELRLEEENRRLLELMKVKAKEAEETDNEDEEEIEGDELEVHEEPEASHDTRGSWLPE EFEASEVPETEPEAVSEPIEETTVETEIPKGSKEGLEIEKLSETVVLPEFPEDSYPDVPEMEPFKEKIGSFIILWKQLEATISEAYIKIL NLEIADRTPQELLQKVVETMEKPFQYTAWELTGEDYEEETEDYQTEAEVDEELEEEEEEEGEDKMKERKRHLGDTKHFCPVVLKENFILQ PGNTEEAAKYREKIYYFSSAEAKEKFLEHPEDYVAHEEPLKAPPLRICLVGPQGSGKTMCGRQLAEKLNIFHIQFEEVLQEKLLLKTEKK VGPEFEEDSENEQAAKQELEELAIQANVKVEEENTKKQLPEVQLTEEEEVIKSSLMENEPLPPEILEVILSEWWLKEPIRSTGFILDGFP RYPEEAQFLGDRGFFPDAAVFIQVDDQDIFDRLLPAQIEKWKLKQKKKLERKKLIKDMKAKIRVDTIAKRRAELILERDKKRRENVVRDD EEISEEELEEDNDDIENILEDEFPKDEEEMSGEEDEEQETDAIERLRGELGEKFEADTHNLQIIQDELERYLIPIISINGARRNHIVQYT LNMKLKPLVENRASIFEKCHPIPAPLAQKMLTFTYKYISSFGYWDPVKLSEGETIKPVENAENPIYPVIHRQYIYFLSSKETKEKFMKNP IKYIRQPKPKPTVPIRIIIVGPPKSGKTTVAKKITSEYGLKHLSIGGALRYVLNNHPETELALMLNWHLHKGMTAPDELAIQALELSLME SVCNTAGVVIDGYPVTKHQMNLLEARSIIPMVIFELSVPSKEIFKRLLLEKENEQRLPYPLHNSAQIVAVNNVKYRKNIGEIRQYYQEQH QNWYVIDGFHSKWWVWNEVIKNVQMVNKYMQTYLERIKAGKAACIDKLCITPQELLSRLGEFEQFCPVSLAESQELFDCSATDSLEFAAE FRGHYYKMSSQEKLNKFLENPELYVPPLAPHPLPSADMIPKRLTLSELKSRFPKCAELQGYCPVTYKDGNQRYEALVPGSINYALEYHNR IYICENKEKLQKFLRSPLKYWEQKLPHKLPPLREPILLTSLPLPGYLEQGIATSLIKAMNAAGCLKPKFPFLSIRRSALLYIALHLKAFN -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ATG5-AK9 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ATG5-AK9 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ATG5-AK9 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ATG5 | C0002871 | Anemia | 1 | CTD_human |
Hgene | ATG5 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Hgene | ATG5 | C0019209 | Hepatomegaly | 1 | CTD_human |
Hgene | ATG5 | C0023380 | Lethargy | 1 | CTD_human |
Hgene | ATG5 | C0024312 | Lymphopenia | 1 | CTD_human |
Hgene | ATG5 | C0027540 | Necrosis | 1 | CTD_human |
Hgene | ATG5 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Hgene | ATG5 | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | ATG5 | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
Hgene | ATG5 | C1262477 | Weight decreased | 1 | CTD_human |
Hgene | ATG5 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Hgene | ATG5 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Hgene | ATG5 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Hgene | ATG5 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Hgene | ATG5 | C4539808 | SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25 | 1 | UNIPROT |
Tgene | C0751883 | Congenital Myasthenic Syndromes, Postsynaptic | 1 | ORPHANET |